Alexandra Harris - Publications

Affiliations: 
2015-2018 Biomedical Sciences University of Virginia, Charlottesville, VA 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tang W, Zhang F, Byun JS, Dorsey TH, Yfantis HG, Ajao A, Liu H, Pichardo MS, Pichardo CM, Harris AR, Yang XR, Figueroa JD, Sayed S, Makokha FW, Ambs S. Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients. Cancer Research Communications. 3: 2244-2255. PMID 37902422 DOI: 10.1158/2767-9764.CRC-23-0165  0.328
2023 Harris AR, Panigrahi G, Liu H, Koparde VN, Bailey-Whyte M, Dorsey TH, Yates CC, Ambs S. Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor Ancestry. Cancer Research Communications. 3: 2014-2029. PMID 37732899 DOI: 10.1158/2767-9764.CRC-23-0236  0.308
2023 Conroy M, Kamaraju S, Powell M, Harris A, Beckius A, Nagavally S, Dawson A, Min H, Wright T, Wainaina N, Binder AF. Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. Clinical Breast Cancer. PMID 37482498 DOI: 10.1016/j.clbc.2023.07.001  0.316
2022 Harris AR, Esparza S, Azimi MS, Cornelison R, Azar FN, Llaneza DC, Belanger M, Mathew A, Tkachenko S, Perez MJ, Rosean CB, Bostic RR, Cornelison RC, Tate KM, Peirce-Cottler SM, et al. Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy. Frontiers in Oncology. 12: 801764. PMID 35372032 DOI: 10.3389/fonc.2022.801764  0.664
2022 Beeghly GF, Thomas C, Yuan JX, Harris AR, Munson JM. Designing Patient-Driven, Tissue-Engineered Models of Primary and Metastatic Breast Cancer. Bioengineering (Basel, Switzerland). 9. PMID 35200398 DOI: 10.3390/bioengineering9020044  0.557
2019 Shim S, Belanger MC, Harris AR, Munson JM, Pompano RR. Two-way communication between ex vivo tissues on a microfluidic chip: application to tumor-lymph node interaction. Lab On a Chip. PMID 30742147 DOI: 10.1039/C8Lc00957K  0.574
2018 Harris AR, Perez MJ, Munson JM. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. Bmc Cancer. 18: 718. PMID 29976154 DOI: 10.1186/s12885-018-4619-8  0.656
2017 Harris AR, Yuan JX, Munson JM. Assessing multiparametric drug response in tissue engineered tumor microenvironment models. Methods (San Diego, Calif.). PMID 29258924 DOI: 10.1016/j.ymeth.2017.12.010  0.558
2014 de Jong PR, Mo JH, Harris AR, Lee J, Raz E. STAT3: An Anti-Invasive Factor in Colorectal Cancer? Cancers. 6: 1394-407. PMID 24995503 DOI: 10.3390/cancers6031394  0.308
Show low-probability matches.